RecruitingNCT05843214

Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements

Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements in Postoperative Resuscitation Neurosurgery


Sponsor

Centre Hospitalier Universitaire de la Réunion

Enrollment

230 participants

Start Date

Feb 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Non-invasive neuromonitoring tools such as transcranial doppler, optic nerve envelope diameter measurement and quantitative pupillometry are routinely used in acute brain injured patients as part of multimodal neuromonitoring with the aim, among others, of detecting episodes of intracranial hypertension, each method allowing the study of one of the different pathophysiological mechanisms of its impact. However, at present there is no data in the literature on the value of these non-invasive neuromonitoring tools in the management of patients undergoing controlled intracranial surgery. The study aims to help the early detection of postoperative neurological deterioration.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Regulated intracranial surgery: scheduled \> 48 hours
  • French-speaking patient
  • No opposition from the patient or a relative when the patient is unable to consent

Exclusion Criteria4

  • Chronic subdural haematoma
  • Isolated cerebral endovascular procedure
  • Stereotactic biopsy
  • Scheduled ventriculoperitoneal shunt or isolated ventriculocisternostomy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-invasive neuromonitoring evaluation (transcranial doppler, optic nerve envelope diameter and quantitative pupillometry)

4 days Post-operation follow-up. Data will be gathered before the surgery and at regular times after the surgery until day 4


Locations(1)

CHU de la Réunion

Saint-Pierre, Reunion

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05843214


Related Trials